Metraipolis › archive › dc_ef48a42de886

SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know — Europe PMC PMID:42783428

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42783428
DOI
10.3390/medsci14050555
License (as archived)
solo-consultazione
Archived
2026-10-15T22:11:46.629Z
SHA-256 of the archived text
ca4f3909311669a9c945e111911cf94f911e85dee4f2524987aed21ebebe96ae
Stable URL of this page
https://metraipolis.com/documento/dc_ef48a42de886

How to cite

SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know — Europe PMC PMID:42783428 — Europe PMC (en), https://europepmc.org/article/MED/42783428 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef48a42de886 (Metraipolis archive dc_ef48a42de886, sha256 ca4f3909311669a9c945e111911cf94f911e85dee4f2524987aed21ebebe96ae)
BibTeX
@misc{dcef48a42de886,
  title = {SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know — Europe PMC PMID:42783428},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42783428},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef48a42de886; sha256 ca4f3909311669a9c945e111911cf94f911e85dee4f2524987aed21ebebe96ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42783428. Agents can read the archived copy with the MCP tool read_document.